| 阿拉丁 |
P125212-10mg |
10mg |
现货 |
501925-31-1 |
PNU-120596,α7烟碱乙酰胆碱受体的正变构调节剂 PNU-120596 |
Moligand™, ≥98%(HPLC) |
331.90
331.90
|
|
| 阿拉丁 |
P125212-50mg |
50mg |
现货 |
501925-31-1 |
PNU-120596,α7烟碱乙酰胆碱受体的正变构调节剂 PNU-120596 |
Moligand™, ≥98%(HPLC) |
687.90
687.90
|
|
| 阿拉丁 |
P409074-1ml |
1ml |
现货 |
501925-31-1 |
PNU-120596 PNU-120596 |
Moligand™, 10mM in DMSO |
274.90
274.90
|
|
| 阿拉丁 |
P125212-100mg |
100mg |
现货 |
501925-31-1 |
PNU-120596,α7烟碱乙酰胆碱受体的正变构调节剂 PNU-120596 |
Moligand™, ≥98%(HPLC) |
1,368.90
1,368.90
|
|
| 阿拉丁 |
P125212-5mg |
5mg |
现货 |
501925-31-1 |
PNU-120596,α7烟碱乙酰胆碱受体的正变构调节剂 PNU-120596 |
Moligand™, ≥98%(HPLC) |
322.90
322.90
|
|
| 麦克林 |
P864660-10mg |
10mg |
|
501925-31-1 |
PNU-120596 PNU-120596 |
|
435.00
435.00
|
|
| 罗恩 |
R028439-50mg |
50mg |
现货 |
501925-31-1 |
α7烟碱乙酰胆碱受体的正变构调节剂 PNU-120596 |
99% |
619.00
619.00
|
|
| 罗恩 |
R028439-10mg |
10mg |
现货 |
501925-31-1 |
α7烟碱乙酰胆碱受体的正变构调节剂 PNU-120596 |
99% |
298.00
298.00
|
|
| 罗恩 |
R028439-250mg |
250mg |
现货 |
501925-31-1 |
α7烟碱乙酰胆碱受体的正变构调节剂 PNU-120596 |
99% |
2,336.00
2,336.00
|
|
| GLPBIO |
GC11643-10 |
10mg |
|
501925-31-1 |
PNU-120596 |
|
357.00
357.00
|
|
| GLPBIO |
GC11643-50 |
50mg |
|
501925-31-1 |
PNU-120596 |
|
1,470.00
1,470.00
|
|
| GLPBIO |
GC11643-200 |
200mg |
|
501925-31-1 |
PNU-120596 |
|
4,788.00
4,788.00
|
|
| 源叶 |
S47640-5mg |
5mg |
|
501925-31-1 |
PNU-120596 PNU-120596 |
|
300.00
300.00
|
|
| 源叶 |
S47640-10mg |
10mg |
|
501925-31-1 |
PNU-120596 PNU-120596 |
|
450.00
450.00
|
|
| 源叶 |
S47640-50mg |
50mg |
|
501925-31-1 |
PNU-120596 PNU-120596 |
|
1,800.00
1,800.00
|
|
| 毕得 |
BD141513-50mg |
50mg |
现货 |
501925-31-1 |
1-(5-氯-2,4-二甲氧基苯基)-3-(5-甲基异恶... 1-(5-Chloro-2,4-dimethoxyphe... |
99+% |
687.00
687.00
|
|